-
Mashup Score: 0
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but it’s the arbitrators that jack up prices for those who can least afford them.
Source: Kaiser Health NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
As Mark Cuban works to
Source: www.beckershospitalreview.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 07 out of 10 price-hike drugs weren't necessary, ICER finds - 1 year(s) ago
Of the 10 drugs with the biggest price hikes in 2021, seven lacked new clinical evidence to sponsor their growing price tags, according to the Institute for Clinical and Economic Review’s annual report.
Source: www.beckershospitalreview.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Mark Cuban Cost Plus Drug Co. and pharmacy benefit manager EmsanaRx forged a partnership to launch EmsanaRx Plus Dec. 8.
Source: www.beckershospitalreview.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0FDA approves most expensive drug on market - 1 year(s) ago
The FDA approved a hemophilia B drug with a list price of $3.5 million — which could save the healthcare system millions per patient according to drug maker CSL Behring.
Source: www.beckershospitalreview.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
As the team of 33 at Mark Cuban Cost Plus Drug Co. works to serve its 1.3 million customers, Mr. Cuban told Time his planned next steps for the company that looks to disrupt the $1.4 trillion pharmaceutical industry.
Source: www.beckershospitalreview.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Price of new cancer drugs jumps 53% in 4 years, report finds - 1 year(s) ago
The cost of new cancer drugs taken at home rose more than 25 percent from 2017 to 2021, and the price of all new cancer drugs and infusion treatments jumped 53 percent, according to a Nov. 2 report from California Representative Katie Porter’s office.
Source: www.beckershospitalreview.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2
A small cadre of business-minded foundations collaborated with the private sector to upend rising drug costs and potentially transform the health care industry.
Source: catalyst.nejm.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Payers are steering their members to Mark Cuban's pharmacy - 2 year(s) ago
Mark Cuban’s online pharmacy, Cost Plus Drug Co., is grabbing the attention of insurers, and the company has now nabbed its first payer partner, Capital Blue Cr
Source: www.beckerspayer.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
AstraZeneca CEO Pascal Soriot said the $37 billion pharmaceutical company is unsure of its future in vaccines and expects slower drug rollouts due to the Inflation Reduction Act, according to an exclusive interview with Reuters Aug. 23.
Source: www.beckershospitalreview.comCategories: Healthcare Professionals, Latest HeadlinesTweet
Why Does #Insulin Cost So Much? Big #Pharma Isn’t the Only Player Driving Prices | #drugpricing #PBM https://t.co/81sYDWmr8n